FENG [Phoenix New Media] 6-K: Phoenix New Media Announces Completion of Strategic Investment

[Phoenix New Media Announces Completion of Strategic Investment in Yidian Yidian establishes U.S. subsidiary to develop international version of application BEIJING, April . 29 , 2015 - 30 million in total for a 21% equity stake in Particle. Additionally, f ollowing the clos ing of the transaction , Mr. Shuang Liu, the CEO of ifeng, has been appointed as the] [001-35158 PHOENIX NEW MEDIA LIMITED Sinolight Plaza, Floor 16 No. 4 Qiyang Road Wangjing, Chaoyang District, Beijing, 100102 People’s Republic of China Form 20-F x Form 40-F o o o Yes o No x TABLE OF CONTENTS 2 PHOENIX NEW MEDIA LIMITED]

By | 2016-03-23T10:45:55+00:00 April 29th, 2015|Categories: Chinese Stocks, FENG, Webplus ver|Tags: , , , , , |0 Comments
Read More

HSOL [Hanwha Q CELLS] F-3: Subject to Completion, dated April 29, 2015 Hanwha

[Subject to Completion, dated April 29, 2015 Hanwha Q CELLS Co., Ltd. (a corporation with limited liability incorporated under the laws of the Cayman Islands) Ordinary Shares Preferred Shares Debt Securities Each time we sell securities, we will provide a supplement to this prospectus that contains specific information about the offering and the terms of the securities. The supplement may] [Hanwha Q CELLS Co., Ltd. Hanwha Building 86 Cheonggyecheon-ro, Jung-gu Seoul Korea 29 April 2015 Dear Sirs Hanwha Q CELLS Co., Ltd. Company Registration Statement Prospectus ordinary shares ADSs preferred shares We have acted as Cayman Islands legal advisers to Hanwha Q CELLS Co., Ltd. (the “ 1 Documents Reviewed For the purposes of this opinion, we have reviewed only] [April 29, 2015 Hanwha Q CELLS Co., Ltd. Hanwha Building 86 Cheonggyecheon-ro, Jung-gu Seoul Korea Registration Statement on Form F-3 Re: Ladies and Gentlemen: Company Registration Statement Commission Securities Act Ordinary Shares Preferred Shares Debt Securities Securities Prospectus Prospectus Supplement Indenture Trustee Securities Documents As such counsel and for purposes of our opinions set forth below, we have examined originals] [Consent of Independent Registered Public Accounting Firm Shanghai, the People’s Republic of China April 29, 2015 EX-23.1 4 d884862dex231.htm EX-23.1] [Consent of Independent Auditor’s Report We consent to the use of our report dated April 24, 2015, with respect to the consolidated balance sheets of Hanwha Q CELLS Investment Co., Ltd. as of December 31, 2013 and 2014 and the related consolidated statements of operations and comprehensive income (loss), changes in stockholders’ equity and cash flows for the period from] [Consent of Independent Registered Public Accounting Firm We hereby consent to the use in this Registration Statement on Form F-3 of Hanwha Q CELLS Co., Ltd. of our report dated March 17, 2015 relating to the financial statements of Hanwha Q Cells Malaysia SDN. BHD., which appears in such Registration Statement. We also consent to the reference to us under]

By | 2016-04-03T00:32:03+00:00 April 29th, 2015|Categories: Chinese Stocks, HSOL, Webplus ver|Tags: , , , , , |0 Comments
Read More

SVA [SINOVAC BIOTECH] 20-F: (Original Filing)

[None (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report. 55,809,661 common shares as of December 31, 2014 o Yes x No o Yes x No x Yes o No x Yes o No Large accelerated filer] [List of Subsidiaries 1. Sinovac Biotech (Hong Kong) Ltd., a Hong Kong company 2. Tangshan Yian Biological Engineering Co., Ltd., a PRC company 3. Sinovac Biotech Co., Ltd., a PRC company 4. Sinovac Research and Development Co., Ltd. (formerly known as Beijing Sinovac Biological Technology Co., Ltd.), a PRC company 5. Sinovac (Dalian) Vaccine Technology Co., Ltd., a PRC company] [CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER I, Weidong Yin, certify that: 1. I have reviewed this annual report on Form 20-F of Sinovac Biotech Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION BY THE CHIEF FINANCIAL OFFICER I, Nan Wang, certify that: 1. I have reviewed this annual report on Form 20-F of Sinovac Biotech Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. April 29 , 2015 Weidong Yin Weidong Yin Chief Executive Officer EX-13.1 5 a14-26055_1ex13d1.htm EX-13.1] [CERTIFICATION BY THE CHIEF FINANCIAL OFFICER (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. April 29 , 2015 Nan Wang Chief Financial Officer EX-13.2 6 a14-26055_1ex13d2.htm EX-13.2] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-161827) pertaining to Sinovac Biotech Ltd.’s 2003 Stock Option Plan and the Registration Statement on Form S-8 (No. 333-190980) pertaining to Sinovac Biotech Ltd.’s 2012 Share Incentive Plan of our reports dated April 29, 2015, with respect to] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-161827) pertaining the Company’s 2003 Stock Option Plan and the Registration Statement on Form S-8 (No. 333-190980) pertaining to the Company’s 2012 Share Incentive Plan of our report dated April 29, 2013 with respect to the consolidated financial]

By | 2016-03-16T06:40:41+00:00 April 29th, 2015|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments
Read More

QUNR [Qunar Cayman Islands] 6-K: (Original Filing)

[Qunar Announces Promotion of Senior Management Team and Files Annual Report BEIJING, April 29, 2015 (GLOBE NEWSWIRE) — Qunar Cayman Islands Limited (NASDAQ: QUNR) (“Qunar” or the “Company”), China’s leading mobile and online travel platform, today announced that its board of directors has appointed Ms. Yilu Zhao, previously Chief Strategy Officer of the Company, to Chief Financial Officer of the] [QUNAR CAYMAN ISLANDS LIMITED Sam Hanhui Sun]

By | 2016-03-21T16:11:08+00:00 April 29th, 2015|Categories: Chinese Stocks, QUNR, SEC Original|Tags: , , , , , |0 Comments
Read More

CBPO [China Biologic Products] DEFA14A: (Original Filing)

[SCHEDULE 14A x ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material under Rule 14a-12 CHINA BIOLOGIC PRODUCTS, INC. ________________________________________________________ Payment of Filing Fee (Check the appropriate box): x No fee required ¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of]

By | 2016-03-25T04:38:22+00:00 April 29th, 2015|Categories: CBPO, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal HONG KONG, China, April 29, 2015 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal letter dated] [FORM 6-K CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Yes o No x Other Events On April 2 9 Description]

By | 2016-03-27T09:12:42+00:00 April 29th, 2015|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments
Read More

CHOP [China Gerui Advanced Materials] 6-K: (Original Filing)

[China Gerui Advanced Materials Group Limited Regains Compliance with NASDAQ Listing Requirements CHOP ZHENGZHOU, China, April 28, 2015 /PRNewswire-FirstCall/ -- China Gerui Advanced Materials Group Limited ( As previously announced on March 2, 2015 and March 10, 2015, China Gerui received written notices (the "Notices") from the Listing Qualifications department of The NASDAQ Stock Market ("NASDAQ") indicating that the Company] [FORM 6-K CHINA GERUI ADVANCED MATERIALS GROUP LIMITED 1 Shuanghu Development Zone Xinzheng City Zhengzhou, Henan Province China, 451191 þ o o þ CHINA GERUI ADVANCED MATERIALS GROUP LIMITED April 29, 2015 Edward Meng Chief Financial Officer]

By | 2016-04-03T05:25:03+00:00 April 29th, 2015|Categories: Chinese Stocks, CHOP, SEC Original|Tags: , , , , , |0 Comments
Read More
Skip to toolbar